Annual Shareholders Equity
$83.28 M
-$33.45 M-28.66%
December 31, 2024
Summary
- As of March 13, 2025, BDTX annual stockholders equity is $83.28 million, with the most recent change of -$33.45 million (-28.66%) on December 31, 2024.
- During the last 3 years, BDTX annual shareholders equity has fallen by -$112.61 million (-57.49%).
- BDTX annual shareholders equity is now -72.94% below its all-time high of $307.76 million, reached on December 31, 2020.
Performance
BDTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$83.28 M
-$14.14 M-14.51%
December 31, 2024
Summary
- As of March 13, 2025, BDTX quarterly stockholders equity is $83.28 million, with the most recent change of -$14.14 million (-14.51%) on December 31, 2024.
- Over the past year, BDTX quarterly shareholders equity has stayed the same.
- BDTX quarterly shareholders equity is now -76.56% below its all-time high of $355.26 million, reached on March 31, 2020.
Performance
BDTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BDTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.7% | 0.0% |
| 3 y3 years | -57.5% | -57.5% |
| 5 y5 years | +276.6% | +276.6% |
BDTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.5% | at low | -57.5% | +1.3% |
| 5 y | 5-year | -72.9% | +276.6% | -76.6% | +276.6% |
| alltime | all time | -72.9% | +276.6% | -76.6% | +276.6% |
Black Diamond Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $83.28 M(-28.7%) | $83.28 M(-14.5%) |
| Sep 2024 | - | $97.43 M(-12.2%) |
| Jun 2024 | - | $111.02 M(+6.4%) |
| Mar 2024 | - | $104.31 M(-10.6%) |
| Dec 2023 | $116.74 M(+0.9%) | $116.74 M(-13.1%) |
| Sep 2023 | - | $134.32 M(+63.4%) |
| Jun 2023 | - | $82.20 M(-16.3%) |
| Mar 2023 | - | $98.19 M(-15.1%) |
| Dec 2022 | $115.69 M(-40.9%) | $115.69 M(-13.2%) |
| Sep 2022 | - | $133.23 M(-12.6%) |
| Jun 2022 | - | $152.37 M(-11.7%) |
| Mar 2022 | - | $172.56 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $195.90 M(-36.3%) | $195.90 M(-10.5%) |
| Sep 2021 | - | $218.95 M(-12.8%) |
| Jun 2021 | - | $251.02 M(-10.6%) |
| Mar 2021 | - | $280.75 M(-8.8%) |
| Dec 2020 | $307.76 M(-752.6%) | $307.76 M(-6.0%) |
| Sep 2020 | - | $327.35 M(-4.6%) |
| Jun 2020 | - | $343.13 M(-3.4%) |
| Mar 2020 | - | $355.26 M(-853.4%) |
| Dec 2019 | -$47.16 M(+203.4%) | -$47.16 M(-162.0%) |
| Sep 2019 | - | $76.09 M(-589.6%) |
| Dec 2018 | -$15.54 M(+132.8%) | -$15.54 M |
| Dec 2017 | -$6.67 M | - |
FAQ
- What is Black Diamond Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual shareholders equity year-on-year change?
- What is Black Diamond Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly shareholders equity year-on-year change?
What is Black Diamond Therapeutics annual stockholders equity?
The current annual shareholders equity of BDTX is $83.28 M
What is the all time high annual shareholders equity for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual stockholders equity is $307.76 M
What is Black Diamond Therapeutics annual shareholders equity year-on-year change?
Over the past year, BDTX annual stockholders equity has changed by -$33.45 M (-28.66%)
What is Black Diamond Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BDTX is $83.28 M
What is the all time high quarterly shareholders equity for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly stockholders equity is $355.26 M
What is Black Diamond Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, BDTX quarterly stockholders equity has changed by $0.00 (0.00%)